Venture capital incubates tomorrow's Chinese pharmaceutical giant (VC 258)

<

Needing a solid professional background in the biopharmaceutical industry, Yang Zhi led BioVida with undisputed focus and handily focused on investing.

In the harsh environment caused by the global financial crisis and economic downturn, Yang Zhi, the founder of BioVida China Fund, is still confident to find new investment opportunities. As a vertical investment fund focused on the field of biomedicine, Yang Zhi is very confident in the industry's resistance to the cyclical economic downturn. Although the biomedicine industry has a high technical threshold and a long investment cycle, the general demand for "everyone takes medicine" and the price-insensitive consumption characteristics determine that the industry has good prospects for sustainable development. In addition, once patented technology is formed, monopoly production and pricing privileges can be formed in this field for up to 20 years. "This is in line with Buffett's long-term value investment philosophy." Yang Zhi said.

The experience of the United States also corroborates this. “The middle class is demanding more and more medical services, which has laid a huge demand for the US pharmaceutical industry.” In Yang Zhi ’s eyes, in the 1980s, due to a large number of venture capital funds , And a considerable number of senior medical personnel entered the industry, and eventually cultivated the leading companies in the US pharmaceutical industry today. China's situation today is similar to that of the United States. "The domestic market for Chinese medicine is growing at an average annual rate of 20%, ranking among the top seven in global drug consumption, and by 2015, China will become the top three country in the world for drug consumption." Huge market prospects and stability against economic cycles Yang Zhi decided to set up a biomedical investment fund in China.

The above information source "Venture Investment" is authorized by the China Venture Capital Research Institute (CVCRI) to publish it. All rights reserved. Please indicate the source when reprinting. For more information, please click download to view all articles.
For more information, please refer to Guotaian Financial Education Group Guotaian Education Service Network Contact E-mail:

Type RXZG-7006B Premium

Business Smart LCD TV,Smart LCD TV Screen,Smart LCD Classroom Display

Guangzhou Ruixin Touch Control Technology Co., Ltd. , https://www.weetaach.com